Azathioprine for Ocular Inflammatory Diseases
نویسندگان
چکیده
منابع مشابه
[Role of Azathioprine in steroid resistant non infectious ocular inflammatory diseases].
BACKGROUND Topical and systemic steroids are the first line of treatment of non infectious inflammatory ocular disease. Immunosuppresants are reserved as a second line treatment. AIM To evaluate the role of Azathioprine (AZA) as a coadyuvant immunosuppressive treatment for non infectious ocular inflammatory diseases (OIDs) resistant to systemic steroid therapy in a retrospective, noncomparati...
متن کاملImmunotherapeutic approaches in ocular inflammatory diseases.
This comprehensive review discusses immunotherapeutic approaches to ocular inflammatory diseases, updates information provided in the literature, and presents clinical experiences with an emphasis on autoimmune uveitis at the National Eye Institute, United States. Current medical and surgical therapeutic approaches, including medications such as corticosteroids, anti-metabolites, alkylating age...
متن کاملOcular manifestations of systemic inflammatory diseases.
Inflammation of the eye is often times seen in association with systemic inflammatory diseases. Understanding the various forms of ocular involvement in these conditions is important as untreated ophthalmic involvement can lead to severe vision loss. In addition to providing a basic framework for diagnosis and treatment, this review will highlight the ocular manifestations of the following syst...
متن کاملInterleukin-17 in Various Ocular Surface Inflammatory Diseases
Recently, the association of Th-17 cells or IL-17 with ocular inflammatory diseases such as uveitis, scleritis and dry eye syndrome was discovered. We assessed whether interleukin (IL)-17 was present in the tears of various ocular surface inflammatory diseases and the tear IL-17 concentrations were clinically correlated with various ocular surface inflammatory diseases. We measured concentratio...
متن کاملInduction of durable remission in ocular inflammatory diseases.
PURPOSE To describe a paradigm of care for patients with ocular inflammatory diseases aimed at induction of durable remission. METHODS Retrospective cohort study. The records of 399 patients with ocular inflammatory diseases treated with systemic immunomodulatory therapy (IMT) at the Massachusetts Eye Research and Surgery Institution were reviewed. Durable remission was defined as control of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Ophthalmology
سال: 2009
ISSN: 0002-9394
DOI: 10.1016/j.ajo.2009.05.008